Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70038 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Sangeetha Madhavan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Brain Plasticity Laboratory, Department of Physical Therapy, College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois, U…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Transcranial Direct Current Stimulation. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
Objective
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with limited treatment options. Transcranial direct current stimulation (tDCS) shows promise as a neuromodulatory intervention in various neurological disorders, but its application in ALS, particularly in a remote, home‐based format, remains underexplored. This study investigates the feasibility, safety, and preliminary efficacy of remotely supervised tele‐tDCS in ALS patients.
Methods
This double‐blinded pilot study included 14 spinal‐onset ALS participants randomized into two groups: the intervention group received 72 tele‐tDCS sessions over 24 weeks, and the delayed‐start group received 36 sham sessions followed by 36 tele‐tDCS sessions. Stimulation was delivered at 2 mA for 20 min 3 times a week. Primary outcomes included feasibility, safety, and disease progression measured by the ALS Functional Rating Scale‐Revised (ALSFRS‐R). Adherence and adverse effects were monitored throughout.
Results
Ten participants completed the study, with an overall compliance rate of 98.3%. No serious adverse events were reported, and mild side effects, like itching and tingling, were consistent with tDCS literature. The intervention group demonstrated a significantly slower decline in ALSFRS‐R scores than the delayed‐start group. At 24 weeks, the intervention group had a mean ALSFRS‐R change of −1.7, compared to −13.6 in the delayed‐start group ( p = 0.0018). Additionally, the change in ALSFRS‐R between pre‐ and mid‐intervention significantly differed between groups ( p = 0.0071).
Interpretation
Tele‐tDCS was feasible, safe, and well‐tolerated in individuals with ALS. Preliminary efficacy results suggest that tele‐tDCS may slow disease progression, underscoring the potential of tele‐tDCS as a promising home‐based neuromodulatory intervention in ALS management. Trial Registration: Clinical trial registration: NCT04866771
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Brain Plasticity Laboratory, Department of Physical Therapy, College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois, USA.
- Graduate Program in Rehabilitation Science, College of Applied Health Sciences, University of Illinois Chicago, Chicago, Illinois, USA.
- Graduate Program in Neuroscience, University of Illinois Chicago, Chicago, Illinois, USA.
- Biological Sciences Division, Department of Neurology, University of Chicago, Chicago, Illinois, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, Illinois, USA.
ORCID-Profile: Shravni Deshmukh
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
Madhavan, S., Deshmukh, S., Cummings, M., Doshi, A., Rezania, K., Freels, S., & Sawa, G. (2025). Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70038
Vancouver
Madhavan S, Deshmukh S, Cummings M, Doshi A, Rezania K, Freels S, et al. Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70038
BibTeX
@article{Madhavan2025,
author = {Madhavan, Sangeetha and Deshmukh, Shravni and Cummings, Mark and Doshi, Aditi and Rezania, Kourosh and Freels, Sally and Sawa, Gina},
title = {Home‐Based Tele‐tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70038}
}
EUVIMED